14465 results in Neurology and Clinical Neuroscience
Chapter 17 - Thalamotomy, pallidotomy and subthalamotomy in the management of Parkinson's disease
- from Section III - Surgical Management of Parkinson's Disease
-
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 175-186
-
- Chapter
- Export citation
Contents
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp v-vi
-
- Chapter
- Export citation
Section III - Surgical Management of Parkinson's Disease
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 175-230
-
- Chapter
- Export citation
Chapter 20 - Deep-brain stimulation of the thalamic ventral intermediate nucleus in the management of Parkinson's disease
- from Section III - Surgical Management of Parkinson's Disease
-
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 206-215
-
- Chapter
- Export citation
Chapter 2 - Anticholinergic agents in the management of Parkinson's disease
- from Section I - The Pharmacological Basis for Parkinson's Disease Treatment
-
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 5-12
-
- Chapter
- Export citation
Chapter 1 - The pharmacological basis of Parkinson's disease therapy: an overview
- from Section I - The Pharmacological Basis for Parkinson's Disease Treatment
-
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 1-4
-
- Chapter
- Export citation
Chapter 4 - Monoamine oxidase inhibitors in the management of Parkinson's disease
- from Section I - The Pharmacological Basis for Parkinson's Disease Treatment
-
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 23-33
-
- Chapter
- Export citation
Chapter 13 - Management of disease-related behavioral disturbances in Parkinson's disease
- from Section II - Management of Nonmotor Symptoms of Parkinson's Disease
-
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 127-138
-
- Chapter
- Export citation
Chapter 6 - Subcutaneous, intranasal and transdermal dopamine agonists in the management of Parkinson's disease
- from Section I - The Pharmacological Basis for Parkinson's Disease Treatment
-
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 48-62
-
- Chapter
- Export citation
Section II - Management of Nonmotor Symptoms of Parkinson's Disease
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 93-174
-
- Chapter
- Export citation
Chapter 8 - Catechol-O-methyltransferase inhibitors in the management of Parkinson's disease
- from Section I - The Pharmacological Basis for Parkinson's Disease Treatment
-
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 76-82
-
- Chapter
- Export citation
Acknowledgements
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp xi-xii
-
- Chapter
- Export citation
Chapter 32 - Lessons and challenges of trials involving ancillary therapies for the management of Parkinson's disease
- from Section IV - Clinical Trials in Parkinson's Diease: Lessons, Controversies and Challenges
-
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 349-360
-
- Chapter
- Export citation
Chapter 10 - Management of autonomic dysfunction in Parkinson's disease
- from Section II - Management of Nonmotor Symptoms of Parkinson's Disease
-
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 93-110
-
- Chapter
- Export citation
Chapter 31 - Lessons and challenges of trials for other nonmotor complications of Parkinson's disease
- from Section IV - Clinical Trials in Parkinson's Diease: Lessons, Controversies and Challenges
-
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 337-348
-
- Chapter
- Export citation
Appendices
- from Chapter 4 - Monoamine oxidase inhibitors in the management of Parkinson's disease
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 29-29
-
- Chapter
- Export citation
Chapter 27 - Controversy: globus pallidus internus versus subthalamic nucleus deep-brain stimulation in the management of Parkinson's disease
- from Section IV - Clinical Trials in Parkinson's Diease: Lessons, Controversies and Challenges
-
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 287-296
-
- Chapter
- Export citation
Chapter 16 - Management of pain and neuromuscular complications in Parkinson's disease
- from Section II - Management of Nonmotor Symptoms of Parkinson's Disease
-
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 162-174
-
- Chapter
- Export citation
Chapter 24 - Cerebrospinal fluid and blood biomarkers as outcome measures in clinical trials for Parkinson's disease
- from Section IV - Clinical Trials in Parkinson's Diease: Lessons, Controversies and Challenges
-
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 249-264
-
- Chapter
- Export citation
Section I - The Pharmacological Basis for Parkinson's Disease Treatment
-
- Book:
- Parkinson's Disease
- Published online:
- 05 March 2016
- Print publication:
- 24 March 2016, pp 1-92
-
- Chapter
- Export citation